Crosstree

We’re #hiring. Know anyone who might be interested?

Congratulations to ROI Healthcare Solutions on its acquisition by Acuvance, a national healthcare advisory platform backed by Trinity Hunt Partners. The acquisition expands Acuvance’s footprint in the hospital market and adds expertise to guide clients through complex ERP transformation, while ROI greatly expands the portfolio of complimentary consulting and managed services offered to their health system clients including #strategy, #rcm, #supplychain, #DTX, #analytics, and clinical and financial performance improvement. To close our 60th Healthcare Technology transaction, Crosstree helped ROI confidently select Acuvance as the right strategic partner by: 📊 Presenting ROI’s differentiated ERP implementation and optimization expertise and their value to health system clients 💡 Positioning data and technology capabilities within evolving market trends and buyer priorities to highlight strategic value 💲 Leveraging deep industry relationships with leading Healthcare Technology buyers to support long-term growth and client success Read the full Deal Insights here: https://lnkd.in/ecJfhnSx #HCIT #Workday #interoperability #mergersandacquisitions #investmentbanking Benjamin J. Garber

As the clinical trial landscape continues to decentralize and diversify, understanding the architecture of the patient access space is essential. The PAO Market Map Report offers a comprehensive foundation, with AI-driven analysis of over 3,000 Patient Access Organizations worldwide. By profiling capabilities and estimating revenues across Freestanding, Virtual, Embedded, and Mobile models, the report creates structure where there was once fragmentation. Produced by industryGENOME, in collaboration with WCG and Crosstree, this is a valuable reference point for those making long-range strategic decisions in research infrastructure. 🔗 https://lnkd.in/eyXkJpiX #healthsciences #lifescience #healthcare #clinicaltrials #ai #marketintelligence industryGENOME

The clinical trial ecosystem is increasingly shaped by how and where patients are engaged. Yet, until now, there has been little clarity on the full scope of organizations facilitating this access. The PAO Market Map Report addresses this gap, providing an evidence-based structure to a market valued at over $14.95 billion globally. It incorporates AI-modeled revenue estimates, classification across operational models, and insight into regional dynamics. For operators, investors, and strategists, this resource brings greater precision to planning, diligence, and competitive positioning. 📥 https://lnkd.in/eyXkJpiX #healthsciences #lifescience #healthcare #clinicaltrials #ai #marketintelligence industryGENOME

The patient access segment of the clinical trials space has long lacked a comprehensive classification structure. This new report changes that. Combining AI-assisted classification and bottom-up modeling, the PAO Market Map Report delivers a structured view of over 3,000 organizations operating in a $14.95 billion global market. It includes: • Segmented capability mapping across five access models • Market sizing with geographic stratification • Revenue estimates for major players and emerging entities Built in collaboration with WCG and Crosstree, the report offers a rigorous analytical framework for anyone looking to understand this space in depth. 📘 https://lnkd.in/eyXkJpiX #healthsciences #lifescience #healthcare #clinicaltrials #ai #marketintelligence industryGENOME

As clinical trial sponsors and service providers seek to enhance access and efficiency, strategic decisions require more than directional insight—they need high-fidelity market data. The PAO Market Map Report offers detailed analysis of over 3,000 global Patient Access Organizations, including AI-modeled revenue benchmarks and capability mapping based on the ICCS® methodology. Whether evaluating expansion opportunities, partnerships, or regional positioning, this report equips teams with the detail needed to move with precision. 🔍 https://lnkd.in/eyXkJpiX #clinicaltrials #lifesciences #healthcareinnovation #ai #marketmapping #healthsciences industryGENOME

For those evaluating strategic investment in clinical trial infrastructure, the PAO Market Map Report provides a data-rich foundation. Developed by industryGENOME, WCG, and Crosstree, the report applies AI-powered classification to over 3,000 Patient Access Organizations, offering revenue estimates, capability profiles, and geo-segmented views across a $14.95B market. This kind of bottom-up visibility supports informed thesis development, platform evaluation, and whitespace identification, particularly valuable in a market with growing complexity. 📘 Access the report: https://lnkd.in/ePBrA7eD

The patient access landscape in clinical trials is evolving, and now, for the first time, we have a comprehensive lens on its full scale and structure. The newly released PAO Market Map Report, developed by industryGENOME in collaboration with WCG and Crosstree, offers a granular look at a $14.95 billion global sector encompassing Freestanding, Mobile, Virtual, Provider Embedded, and Service Embedded models. The report combines detailed company profiling, bottom-up AI-driven modeling, and geographic segmentation to offer practical clarity for strategy, investment, and operations. 📘 Access the report: https://lnkd.in/eyXkJpiX